MENU
+Compare
LMAT
Stock ticker: NASDAQ
AS OF
Nov 19, 04:59 PM (EDT)
Price
$86.95
Change
+$0.47 (+0.54%)
Capitalization
1.96B

LMAT stock forecast, quote, news & analysis

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease... Show more

LMAT
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. LMAT showed earnings on November 06, 2025. You can read more about the earnings report here.
Interact to see
Advertisement
A.I.Advisor
a Summary for LMAT with price predictions
Nov 18, 2025

Momentum Indicator for LMAT turns negative, indicating new downward trend

LMAT saw its Momentum Indicator move below the 0 level on November 18, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 94 similar instances where the indicator turned negative. In of the 94 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 67 cases where LMAT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for LMAT turned negative on November 18, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

LMAT moved below its 50-day moving average on November 14, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LMAT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

LMAT broke above its upper Bollinger Band on October 21, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LMAT advanced for three days, in of 334 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 270 cases where LMAT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.208) is normal, around the industry mean (9.047). P/E Ratio (37.496) is within average values for comparable stocks, (152.239). Projected Growth (PEG Ratio) (1.883) is also within normal values, averaging (2.537). Dividend Yield (0.009) settles around the average of (0.017) among similar stocks. P/S Ratio (8.278) is also within normal values, averaging (111.346).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LMAT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
published Dividends

LMAT is expected to pay dividends on December 04, 2025

LeMaitre Vascular LMAT Stock Dividends
A dividend of $0.20 per share will be paid with a record date of December 04, 2025, and an ex-dividend date of November 20, 2025. The last dividend of $0.20 was paid on September 04. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Intuitive Surgical (NASDAQ:ISRG), Align Technology (NASDAQ:ALGN).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 11.71B. The market cap for tickers in the group ranges from 246 to 193.83B. ISRG holds the highest valuation in this group at 193.83B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was -2%. For the same Industry, the average monthly price growth was -0%, and the average quarterly price growth was 9%. TUTH experienced the highest price growth at 85%, while SMTI experienced the biggest fall at -25%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was -7%. For the same stocks of the Industry, the average monthly volume growth was -25% and the average quarterly volume growth was 84%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 61
Price Growth Rating: 61
SMR Rating: 79
Profit Risk Rating: 92
Seasonality Score: 26 (-100 ... +100)
View a ticker or compare two or three
LMAT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a manufacturer of vascular devices for vascular surgeons

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
63 Second Avenue
Phone
+1 781 221-2266
Employees
630
Web
https://www.lemaitre.com